Each week we highlight five things affecting the life sciences industry. Here's the latest. Embracing inclusivity: How biopharmas connect with LGBTQ+ employees Biopharma companies are increasingly creating inclusive workplaces through employee resource groups (ERGs), with 75% of employers now having ... READ MORE >
5 things to know in life sciences: Week of June 3, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma research productivity increases Recent advancements in artificial intelligence are significantly enhancing research and development productivity by streamlining drug discovery processes, leading to ... READ MORE >
5 things to know in life sciences: Week of May 27, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA issues draft guidance on platform technology designation The Food and Drug Administration has released a draft guidance aimed at providing a framework for the designation of platform technologies, which ... READ MORE >
5 things to know in life sciences: Week of May 20, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. New collaboration explores AI-based digital pathology Microsoft is collaborating with researchers from the University of Washington as well as Providence health network to develop a new artificial ... READ MORE >
5 things to know in life sciences: Week of May 13, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA approves new self-collection approach to cervical cancer screening According to the Washington Post, the Food and Drug Administration has approved a newly developed screening test for cervical cancer that ... READ MORE >
5 things to know in life sciences: Week of May 6, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Biopharma industry challenges Biosecure Act BioCentury reports that the biopharma industry is actively lobbying for changes to the Biosecure Act aiming to modify legislative measures that could impact U.S. ... READ MORE >
5 things to know in life sciences: Week of April 29, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. FDA releases final rule on laboratory developed tests On April 29, the U.S. Food and Drug Administration issued a final rule regarding regulation of laboratory developed tests, following a proposed rule in ... READ MORE >
5 things to know in life sciences: Week of April 22, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Orphan drug market to reach $270 billion by 2028 despite decreasing growth rates According to data from Evaluate, the orphan drug market is projected to expand to $270 billion by 2028. This sector, while ... READ MORE >
5 things to know in life sciences: Week of April 15, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. EU launches probe into China's medical device market practices According to Reuters, the European Union is set to begin an investigation into China's medical device procurement practices, concerned that ... READ MORE >
5 things to know in life sciences: Week of April 8, 2024
Each week we highlight five things affecting the life sciences industry. Here's the latest. Women-led health tech ventures in Africa experience 2,000% funding growth Funding for women-led health tech ventures in Africa increased from 1% of total funding in 2022 to 31% in 2023, with the amount rising ... READ MORE >